These results are in agreement with our previous results confirming that leukemic cells isolated from AML patients lose their Cx-43 profile in comparison to normal BM-CD34+ cells and overexpress numerous connexins, especially Cx-25 [17]. This evidence concerns the gene CD34 and acute myeloid leukemia.